| Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double‐blind, placebo‐controlled trial SD Silberstein, RB Lipton, DW Dodick, FG Freitag, N Ramadan, ... Headache: The Journal of Head and Face Pain 47 (2), 170-180, 2007 | 572 | 2007 |
| Assessment of interrater and intrarater reliability of the Fahn–Tolosa–Marin Tremor Rating Scale in essential tremor MA Stacy, RJ Elble, WG Ondo, SC Wu, J Hulihan, TRS Study Group Movement disorders 22 (6), 833-838, 2007 | 317 | 2007 |
| A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis ME Cudkowicz, JM Shefner, DA Schoenfeld, RH Brown Jr, H Johnson, ... Neurology 61 (4), 456-464, 2003 | 253 | 2003 |
| Topiramate for migraine prevention in children: a randomized, double‐blind, placebo‐controlled trial P Winner, EM Pearlman, SL Linder, DM Jordan, AC Fisher, J Hulihan, ... Headache: The Journal of Head and Face Pain 45 (10), 1304-1312, 2005 | 220 | 2005 |
| Differential cognitive and behavioral effects of topiramate and valproate KJ Meador, DW Loring, JF Hulihan, M Kamin, R Karim Neurology 60 (9), 1483-1488, 2003 | 206 | 2003 |
| Topiramate in essential tremor: a double-blind, placebo-controlled trial WG Ondo, J Jankovic, GS Connor, R Pahwa, R Elble, MA Stacy, ... Neurology 66 (5), 672-677, 2006 | 202 | 2006 |
| Long‐term follow‐up of stereotactic lesionectomy in partial epilepsy: predictive factors and electroencephalographic results GD Cascino, PJ Kelly, FW Sharbrough, JF Hulihan, KA Hirschorn, ... Epilepsia 33 (4), 639-644, 1992 | 201 | 1992 |
| Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse HC Diener, DW Dodick, PJ Goadsby, ME Bigal, G Bussone, ... Cephalalgia 29 (10), 1021-1027, 2009 | 189 | 2009 |
| Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs DW Dodick, F Freitag, J Banks, J Saper, J Xiang, M Rupnow, D Biondi, ... Clinical therapeutics 31 (3), 542-559, 2009 | 179 | 2009 |
| Topiramate treatment of chronic migraine: A randomized, placebo‐controlled trial of quality of life and other efficacy measures S Silberstein, R Lipton, D Dodick, F Freitag, N Mathew, J Brandes, M Bigal, ... Headache: The Journal of Head and Face Pain 49 (8), 1153-1162, 2009 | 163 | 2009 |
| Topiramate dose effects on cognition: a randomized double-blind study DW Loring, DJ Williamson, KJ Meador, F Wiegand, J Hulihan Neurology 76 (2), 131-137, 2011 | 135 | 2011 |
| Parietal lobe lesional epilepsy: electroclinical correlation and operative outcome GD Cascino, JF Hulihan, FW Sharbrough, PJ Kelly Epilepsia 34 (3), 522-527, 1993 | 131 | 1993 |
| Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial KNR Chengappa, LK Schwarzman, JF Hulihan, J Xiang, NR Rosenthal, ... Journal of Clinical Psychiatry 67 (11), 1698-1706, 2006 | 96 | 2006 |
| Stump pressure, electroencephalographic changes, and the contralateral carotid artery: another look at selective shunting RN Harada, AJ Comerota, GM Good, HA Hashemi, JF Hulihan The American journal of surgery 170 (2), 148-153, 1995 | 90 | 1995 |
| The impact of topiramate on health‐related quality of life indicators in chronic migraine DW Dodick, S Silberstein, J Saper, FG Freitag, RK Cady, AM Rapoport, ... Headache: The Journal of Head and Face Pain 47 (10), 1398-1408, 2007 | 83 | 2007 |
| Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study SD Silberstein, J Hulihan, MR Karim, SC Wu, D Jordan, D Karvois, ... Clinical therapeutics 28 (7), 1002-1011, 2006 | 75 | 2006 |
| Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials KR Edwards, DL Potter, SC Wu, M Kamin, J Hulihan CNS spectrums 8 (6), 428-432, 2003 | 66 | 2003 |
| Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study RB Lipton, S Silberstein, D Dodick, R Cady, F Freitag, N Mathew, ... Cephalalgia 31 (1), 18-30, 2011 | 64 | 2011 |
| Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials J Adelman, FG Freitag, M Lainez, Y Shi, S Ascher, L Mao, S Greenberg, ... Pain medicine 9 (2), 175-185, 2008 | 62 | 2008 |
| Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate S Silberstein, HC Diener, R Lipton, P Goadsby, D Dodick, G Bussone, ... Headache: The Journal of Head and Face Pain 48 (7), 1087-1095, 2008 | 51 | 2008 |
